Variant report
Variant | nsv520912 |
---|---|
Chromosome Location | chr9:11254070-11308992 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:66)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr9:11272473-11272479 | Hela-S3 | cervix: | n/a | n/a |
2 | CBX3 | chr9:11269115-11269340 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr9:11258134-11258408 | HepG2 | liver: | n/a | chr9:11258233-11258244 |
4 | CEBPB | chr9:11258090-11258374 | MCF-7 | breast: | n/a | chr9:11258233-11258244 |
5 | CEBPB | chr9:11258095-11258408 | IMR90 | lung: | n/a | chr9:11258233-11258244 |
6 | CEBPB | chr9:11267017-11267301 | K562 | blood: | n/a | chr9:11267135-11267146 |
7 | CEBPB | chr9:11258112-11258312 | K562 | blood: | n/a | chr9:11258233-11258244 |
8 | CEBPB | chr9:11266996-11267317 | IMR90 | lung: | n/a | chr9:11267135-11267146 |
9 | CEBPB | chr9:11257560-11257807 | HepG2 | liver: | n/a | n/a |
10 | CEBPB | chr9:11267004-11267299 | HepG2 | liver: | n/a | chr9:11267135-11267146 |
11 | CEBPB | chr9:11258136-11258368 | H1-hESC | embryonic stem cell: | n/a | chr9:11258233-11258244 |
12 | CEBPB | chr9:11294410-11294610 | HepG2 | liver: | n/a | n/a |
13 | CEBPB | chr9:11258112-11258370 | A549 | lung: | n/a | chr9:11258233-11258244 |
14 | CTCF | chr9:11291462-11291489 | GM10248 | blood: | n/a | n/a |
15 | CTCF | chr9:11267628-11267697 | Lung_OC | lung: | n/a | n/a |
16 | CTCF | chr9:11292504-11292560 | GM13976 | blood: | n/a | n/a |
17 | CTCF | chr9:11266011-11266069 | Kidney_OC | kidney: | n/a | n/a |
18 | CTCF | chr9:11256206-11256235 | GM10266 | blood: | n/a | n/a |
19 | CTCF | chr9:11256655-11256708 | GM13976 | blood: | n/a | n/a |
20 | CTCF | chr9:11300853-11300916 | Pancreas_OC | pancreas: | n/a | n/a |
21 | CTCF | chr9:11293769-11293802 | Kidney_OC | kidney: | n/a | n/a |
22 | CTCF | chr9:11293809-11293811 | Kidney_OC | kidney: | n/a | n/a |
23 | CTCF | chr9:11266027-11266077 | LNCaP | prostate: | n/a | n/a |
24 | CTCF | chr9:11273460-11273610 | GM12866 | blood: | n/a | n/a |
25 | E2F4 | chr9:11283208-11283408 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | E2F4 | chr9:11274565-11274765 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | E2F4 | chr9:11272521-11272714 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | EP300 | chr9:11269259-11269265 | K562 | blood: | n/a | n/a |
29 | FOS | chr9:11298684-11298876 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | FOXP2 | chr9:11264566-11264802 | SK-N-MC | brain: | n/a | n/a |
31 | GABPA | chr9:11300066-11300142 | HepG2 | liver: | n/a | n/a |
32 | GABPA | chr9:11300064-11300154 | HepG2 | liver: | n/a | n/a |
33 | GATA3 | chr9:11257913-11258463 | MCF-7 | breast: | n/a | n/a |
34 | JUND | chr9:11298708-11298978 | HepG2 | liver: | n/a | chr9:11298832-11298843 |
35 | KAP1 | chr9:11307549-11307915 | HEK293 | kidney: | n/a | n/a |
36 | KAP1 | chr9:11268945-11269640 | K562 | blood: | n/a | n/a |
37 | KAP1 | chr9:11268917-11269615 | HEK293 | kidney: | n/a | n/a |
38 | MAFK | chr9:11305411-11305640 | HepG2 | liver: | n/a | n/a |
39 | MAFK | chr9:11305407-11305602 | IMR90 | lung: | n/a | n/a |
40 | MAFK | chr9:11277023-11277138 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | MAZ | chr9:11276668-11276729 | HepG2 | liver: | n/a | n/a |
42 | MYC | chr9:11261363-11261502 | GM12878 | blood: | n/a | n/a |
43 | POLR2A | chr9:11289170-11289286 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | POLR2A | chr9:11296267-11296421 | A549 | lung: | n/a | n/a |
45 | POLR2A | chr9:11296464-11296547 | MCF-7 | breast: | n/a | n/a |
46 | POLR2A | chr9:11296483-11296484 | MCF-7 | breast: | n/a | n/a |
47 | POLR2A | chr9:11281812-11281827 | Gliobla | brain: | n/a | n/a |
48 | POLR2A | chr9:11265081-11265138 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | POLR2A | chr9:11273100-11273121 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr9:11264401-11264962 | SK-N-MC | brain: | n/a | n/a |
No data |
No data |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-9 | chr9:11265314-11265536 | NONHSAT130211 |
2 | lnc-TYRP1-2 | chr9:11277792-11277964 | XLOC_007281 |
3 | lnc-PTPRD-9 | chr9:11266253-11266314 | NONHSAT130211 |
4 | lnc-PTPRD-4 | chr9:11275314-11275536 | XLOC_007646 |
5 | lnc-TYRP1-2 | chr9:11277589-11277655 | XLOC_007281 |
6 | lnc-PTPRD-4 | chr9:11276253-11276314 | XLOC_007646 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000230365 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10959669 | chr9:11254204-11254205 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189334409 | chr9:11254228-11254229 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571892201 | chr9:11254267-11254268 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536909656 | chr9:11254274-11254275 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1158666 | chr9:11254279-11254280 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs10959670 | chr9:11254284-11254285 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs542198057 | chr9:11254290-11254291 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180713025 | chr9:11254297-11254298 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186356799 | chr9:11254298-11254299 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140227642 | chr9:11254304-11254305 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10115315 | chr9:11254334-11254335 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs10115316 | chr9:11254344-11254345 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs551038643 | chr9:11254349-11254350 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558881051 | chr9:11254371-11254372 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12003565 | chr9:11254373-11254374 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs140909310 | chr9:11254418-11254419 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530073656 | chr9:11254428-11254429 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577231047 | chr9:11254432-11254433 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191307044 | chr9:11254477-11254478 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566995331 | chr9:11254478-11254479 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539103299 | chr9:11254513-11254514 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372535635 | chr9:11254557-11254558 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375413017 | chr9:11254581-11254582 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571397481 | chr9:11254586-11254587 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181146106 | chr9:11254619-11254620 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557006664 | chr9:11254628-11254629 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185979701 | chr9:11254642-11254643 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12351724 | chr9:11254673-11254674 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs28875890 | chr9:11254678-11254679 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572611907 | chr9:11254700-11254701 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73408926 | chr9:11254714-11254715 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs569850377 | chr9:11254717-11254718 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532480141 | chr9:11254732-11254733 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573568750 | chr9:11254741-11254742 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570106589 | chr9:11257423-11257424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548533972 | chr9:11257430-11257431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529444141 | chr9:11257441-11257442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139866794 | chr9:11257444-11257445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10959672 | chr9:11257448-11257449 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
40 | rs534717287 | chr9:11257476-11257477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114744247 | chr9:11257501-11257502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs571722060 | chr9:11257508-11257509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537101283 | chr9:11257529-11257530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557423764 | chr9:11257571-11257572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs534603005 | chr9:11257590-11257591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192156511 | chr9:11257617-11257618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11496219 | chr9:11257638-11257639 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs183802049 | chr9:11257642-11257643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111503732 | chr9:11257657-11257658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186189602 | chr9:11257670-11257671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11254200-11254800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
2 | chr9:11257400-11258600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr9:11257600-11258000 | Enhancers | Fetal Heart | heart |
4 | chr9:11258000-11258400 | Flanking Active TSS | Fetal Heart | heart |
5 | chr9:11258200-11258600 | Enhancers | Placenta Amnion | Placenta Amnion |
6 | chr9:11258200-11258800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr9:11258200-11258800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr9:11258400-11259000 | Enhancers | Fetal Heart | heart |
9 | chr9:11258800-11259800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
10 | chr9:11259200-11260200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr9:11259400-11259800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr9:11259800-11260000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr9:11268800-11269600 | ZNF genes & repeats | Adipose Nuclei | Adipose |
14 | chr9:11280400-11281000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
15 | chr9:11280600-11281000 | Enhancers | Fetal Brain Female | brain |
16 | chr9:11280800-11281200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr9:11295400-11297000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr9:11296400-11296600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr9:11296600-11300800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr9:11297000-11297400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr9:11300800-11301000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |